Randomized Clinical Trial of RN316 (PF-04950615) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events (SPIRE-LDL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Pfizer
Sponsor:
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT01968967
First received: October 21, 2013
Last updated: July 24, 2014
Last verified: July 2014
  Purpose

This study is a multicenter, randomized study in subjects with high cholesterol receiving highly effective statins to assess the efficacy, safety and tolerability of RN316 (PF-04950615) to lower LDL-C.


Condition Intervention Phase
Hyperlipidemia
Drug: PF-04950615
Other: Placebo
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study To Assess The Efficacy, Long-Term Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Resource links provided by NLM:


Further study details as provided by Pfizer:

Primary Outcome Measures:
  • Percent Change from Baseline in LDL-C at Week 12 [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Low Density Lipoprotein Cholesterol (LDL-C)


Secondary Outcome Measures:
  • Change from Baseline in Lipid Parameters at Week 12 [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Percent change in Total Cholesterol (TC), Apolipoprotein B (Apo B), non-HDL-C, LDL-C by TG level (< or >+ 200 mg/dL), Lipoprotein (a) (Lp(a), High Density Lipoprotein (HDL), Triglyceride, ApoA-I, and ApoA-II blood concentrations.

  • Change from Baseline in Lipid Parameters at Week 24 [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
    Low Density Lipoprotein (LDL), Mean Total Cholesterol (TC), High Density Lipoprotein (HDL), Triglyceride, ApoA-I, and ApoA-II blood concentrations.

  • Change from Baseline in Lipid Parameters at Week 52 [ Time Frame: 52 weeks ] [ Designated as safety issue: No ]
    Low Density Lipoprotein (LDL), Mean Total Cholesterol (TC), High Density Lipoprotein (HDL), Triglyceride, ApoA-I, and ApoA-II blood concentrations.

  • Proportion of Subjects Achieving Fasting LDL-C <= 100 mg/dL and <=70 mg/dL [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Proportion of Subjects Achieving Fasting LDL-C <= 100 mg/dL and <=70 mg/dL

  • Proportion of Subjects Achieving Fasting LDL-C <= 100 mg/dL and <=70 mg/dL [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
    Proportion of Subjects Achieving Fasting LDL-C <= 100 mg/dL and <=70 mg/dL

  • Proportion of Subjects Achieving Fasting LDL-C <= 100 mg/dL and <=70 mg/dL [ Time Frame: 52 weeks ] [ Designated as safety issue: No ]
    Proportion of Subjects Achieving Fasting LDL-C <= 100 mg/dL and <=70 mg/dL

  • Plasma PF-04950615 concentration [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
    Plasma PF-04950615 concentration

  • Plasma PF-04950615 concentration [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
    Plasma PF-04950615 concentration

  • Plasma PF-04950615 concentration [ Time Frame: 52 weeks ] [ Designated as safety issue: No ]
    Plasma PF-04950615 concentration


Estimated Enrollment: 1600
Study Start Date: October 2013
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: PF-04950615 Drug: PF-04950615
150 mg every 2 weeks, subcutaneous injection, 18 months
Other Name: RN316
Placebo Comparator: Placebo Other: Placebo
subcutaneous injection every 2 weeks for 18 months

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Treated with a statin.
  • Fasting LDL-C > 70 mg/dL and triglyceride <=400 mg/dL.
  • High or very high risk of incurring a cardiovascular event.

Exclusion Criteria:

  • Pregnant or breastfeeding females.
  • Cardiovascular or cerebrovascular event of procedures during the past 30 days.
  • Congestive heart failure NYHA class IV.
  • Poorly controlled hypertension.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01968967

Contacts
Contact: Pfizer CT.gov Call Center 1-800-718-1021

  Hide Study Locations
Locations
United States, Alabama
Pfizer Investigational Site Recruiting
Athens, Alabama, United States, 35611
Pfizer Investigational Site Not yet recruiting
Birmingham, Alabama, United States, 35294
Pfizer Investigational Site Not yet recruiting
Birmingham, Alabama, United States, 35235
United States, Arizona
Pfizer Investigational Site Not yet recruiting
Glendale, Arizona, United States, 85308
Pfizer Investigational Site Recruiting
Phoenix, Arizona, United States, 85018
Pfizer Investigational Site Recruiting
Tempe, Arizona, United States, 85282
Pfizer Investigational Site Recruiting
Tucson, Arizona, United States, 85710
Pfizer Investigational Site Recruiting
Tucson, Arizona, United States, 85710-2193
United States, California
Pfizer Investigational Site Not yet recruiting
Fresno, California, United States, 93703
Pfizer Investigational Site Recruiting
Huntington Beach, California, United States, 92648
Pfizer Investigational Site Recruiting
Huntington Park, California, United States, 90255
Pfizer Investigational Site Recruiting
Los Gatos, California, United States, 95032
Pfizer Investigational Site Not yet recruiting
Northridge, California, United States, 91324
Pfizer Investigational Site Recruiting
Poway, California, United States, 92064
Pfizer Investigational Site Recruiting
Sacramento, California, United States, 95821
Pfizer Investigational Site Not yet recruiting
San Diego, California, United States, 92101
Pfizer Investigational Site Recruiting
Tustin, California, United States, 92780
Pfizer Investigational Site Recruiting
Walnut Creek, California, United States, 94598
Pfizer Investigational Site Recruiting
West Hills, California, United States, 91307
United States, Colorado
Pfizer Investigational Site Recruiting
Colorado Springs, Colorado, United States, 80904
Pfizer Investigational Site Recruiting
Colorado Springs, Colorado, United States, 80906
Pfizer Investigational Site Not yet recruiting
GOlden, Colorado, United States, 80401
United States, Connecticut
Pfizer Investigational Site Recruiting
Guilford, Connecticut, United States, 06437
United States, Florida
Pfizer Investigational Site Recruiting
Atlantis, Florida, United States, 33462
Pfizer Investigational Site Recruiting
DeLand, Florida, United States, 32720
Pfizer Investigational Site Recruiting
Fleming Island, Florida, United States, 32003
Pfizer Investigational Site Recruiting
Fort Lauderdale, Florida, United States, 33308
Pfizer Investigational Site Recruiting
Gainesville, Florida, United States, 32605
Pfizer Investigational Site Recruiting
Hialeah, Florida, United States, 33016
Pfizer Investigational Site Recruiting
Hialeah, Florida, United States, 33012
Pfizer Investigational Site Recruiting
Inverness, Florida, United States, 34452
Pfizer Investigational Site Recruiting
Jacksonville, Florida, United States, 32216
Pfizer Investigational Site Recruiting
Jacksonville, Florida, United States, 32205
Pfizer Investigational Site Recruiting
Miami, Florida, United States, 33183
Pfizer Investigational Site Recruiting
Miami, Florida, United States, 33126
Pfizer Investigational Site Not yet recruiting
Miami, Florida, United States, 33126
Pfizer Investigational Site Recruiting
Miami, Florida, United States, 33144
Pfizer Investigational Site Recruiting
Miami, Florida, United States, 33015
Pfizer Investigational Site Recruiting
Miami, Florida, United States, 33185
Pfizer Investigational Site Recruiting
Pembroke Pines, Florida, United States, 33024
Pfizer Investigational Site Recruiting
Virginia Gardens, Florida, United States, 33166
Pfizer Investigational Site Recruiting
West Palm Beach, Florida, United States, 33401
Pfizer Investigational Site Recruiting
Winter Haven, Florida, United States, 33880
United States, Georgia
Pfizer Investigational Site Recruiting
Atlanta, Georgia, United States, 30318
Pfizer Investigational Site Recruiting
Roswell, Georgia, United States, 30075
Pfizer Investigational Site Recruiting
Woodstock, Georgia, United States, 30189
United States, Hawaii
Pfizer Investigational Site Recruiting
Honolulu, Hawaii, United States, 96814
United States, Idaho
Pfizer Investigational Site Not yet recruiting
Boise, Idaho, United States, 83704
Pfizer Investigational Site Recruiting
Idaho Falls, Idaho, United States, 83402
United States, Illinois
Pfizer Investigational Site Not yet recruiting
Melrose Park, Illinois, United States, 60160
United States, Indiana
Pfizer Investigational Site Recruiting
Brownsburg, Indiana, United States, 46112
Pfizer Investigational Site Recruiting
Indianapolis, Indiana, United States, 46254
Pfizer Investigational Site Recruiting
Indianapolis, Indiana, United States, 46260
Pfizer Investigational Site Recruiting
Valparaiso, Indiana, United States, 46383
United States, Iowa
Pfizer Investigational Site Recruiting
Council Bluffs, Iowa, United States, 51501
Pfizer Investigational Site Recruiting
Iowa City, Iowa, United States, 52242
United States, Louisiana
Pfizer Investigational Site Recruiting
Metairie, Louisiana, United States, 70006
Pfizer Investigational Site Recruiting
New Orleans, Louisiana, United States, 70119
United States, Maryland
Pfizer Investigational Site Recruiting
Columbia, Maryland, United States, 21045
Pfizer Investigational Site Recruiting
Oxon Hill, Maryland, United States, 20745
United States, Michigan
Pfizer Investigational Site Recruiting
Bingham Farms, Michigan, United States, 48025
Pfizer Investigational Site Not yet recruiting
Chelsea, Michigan, United States, 48118
Pfizer Investigational Site Recruiting
Troy, Michigan, United States, 48085
United States, Minnesota
Pfizer Investigational Site Recruiting
Edina, Minnesota, United States, 55435
United States, Missouri
Pfizer Investigational Site Recruiting
Kansas City, Missouri, United States, 64106
Pfizer Investigational Site Recruiting
Washington, Missouri, United States, 63090
United States, Nevada
Pfizer Investigational Site Recruiting
Las Vegas, Nevada, United States, 89121
Pfizer Investigational Site Recruiting
Las Vegas, Nevada, United States, 89119
United States, New Jersey
Pfizer Investigational Site Not yet recruiting
Elizabeth, New Jersey, United States, 07202
Pfizer Investigational Site Recruiting
Trenton, New Jersey, United States, 08611
United States, New York
Pfizer Investigational Site Recruiting
Albany, New York, United States, 12206
Pfizer Investigational Site Recruiting
New Windsor, New York, United States, 12553
Pfizer Investigational Site Recruiting
Syracuse, New York, United States, 13202
United States, North Carolina
Pfizer Investigational Site Recruiting
Charlotte, North Carolina, United States, 28277
Pfizer Investigational Site Recruiting
Greensboro, North Carolina, United States, 27408
Pfizer Investigational Site Recruiting
Salisbury, North Carolina, United States, 28144
Pfizer Investigational Site Recruiting
Wilmington, North Carolina, United States, 28401
Pfizer Investigational Site Recruiting
Winston-Salem, North Carolina, United States, 27013
United States, Ohio
Pfizer Investigational Site Recruiting
Akron, Ohio, United States, 44311
Pfizer Investigational Site Not yet recruiting
Canal Fulton, Ohio, United States, 44614
Pfizer Investigational Site Recruiting
Cincinnati, Ohio, United States, 45236
Pfizer Investigational Site Recruiting
Cincinnati, Ohio, United States, 45219
Pfizer Investigational Site Recruiting
Cincinnati, Ohio, United States, 45227
Pfizer Investigational Site Recruiting
Cincinnati, Ohio, United States, 45246
Pfizer Investigational Site Recruiting
Cincinnati, Ohio, United States, 45212
United States, Oklahoma
Pfizer Investigational Site Recruiting
Norman, Oklahoma, United States, 73069
United States, Oregon
Pfizer Investigational Site Recruiting
Medford, Oregon, United States, 97504
United States, Pennsylvania
Pfizer Investigational Site Recruiting
Darby, Pennsylvania, United States, 19023
Pfizer Investigational Site Recruiting
Downingtown, Pennsylvania, United States, 19335
Pfizer Investigational Site Recruiting
Duncansville, Pennsylvania, United States, 16635
Pfizer Investigational Site Not yet recruiting
Erie, Pennsylvania, United States, 16506
Pfizer Investigational Site Not yet recruiting
Erie, Pennsylvania, United States, 16508
Pfizer Investigational Site Recruiting
Lansdale, Pennsylvania, United States, 19446
Pfizer Investigational Site Recruiting
Pittsburgh, Pennsylvania, United States, 15212
Pfizer Investigational Site Not yet recruiting
Sayre, Pennsylvania, United States, 18840
Pfizer Investigational Site Recruiting
Warminster, Pennsylvania, United States, 18974
United States, South Carolina
Pfizer Investigational Site Recruiting
Charleston, South Carolina, United States, 29407
Pfizer Investigational Site Recruiting
Greenville, South Carolina, United States, 29615
Pfizer Investigational Site Recruiting
North Charleston, South Carolina, United States, 29406
Pfizer Investigational Site Recruiting
Summerville, South Carolina, United States, 29485
United States, Texas
Pfizer Investigational Site Recruiting
Dallas, Texas, United States, 75230
Pfizer Investigational Site Recruiting
Dallas, Texas, United States, 75231
Pfizer Investigational Site Recruiting
Houston, Texas, United States, 77070
Pfizer Investigational Site Recruiting
Houston, Texas, United States, 77081
Pfizer Investigational Site Recruiting
Houston, Texas, United States, 77030
Pfizer Investigational Site Recruiting
Houston, Texas, United States, 77099
Pfizer Investigational Site Recruiting
New Braunfels, Texas, United States, 78130
Pfizer Investigational Site Not yet recruiting
Plano, Texas, United States, 75093
Pfizer Investigational Site Recruiting
San Antonio, Texas, United States, 78215
Pfizer Investigational Site Recruiting
San Antonio, Texas, United States, 78249
Pfizer Investigational Site Recruiting
Sugar Land, Texas, United States, 77479
Pfizer Investigational Site Recruiting
Tomball, Texas, United States, 77375
United States, Utah
Pfizer Investigational Site Recruiting
Murray, Utah, United States, 84123
United States, Virginia
Pfizer Investigational Site Recruiting
Manassas, Virginia, United States, 20110
United States, Washington
Pfizer Investigational Site Recruiting
Renton, Washington, United States, 98057
Pfizer Investigational Site Recruiting
Richland, Washington, United States, 99352
Canada, Ontario
Pfizer Investigational Site Not yet recruiting
Cambridge, Ontario, Canada, N1R 7R1
Pfizer Investigational Site Not yet recruiting
Hamilton, Ontario, Canada, L8L 5G8
Pfizer Investigational Site Not yet recruiting
Newmarket, Ontario, Canada, L3Y 8C3
Pfizer Investigational Site Not yet recruiting
Sarnia, Ontario, Canada, N7T 4X3
Canada, Quebec
Pfizer Investigational Site Not yet recruiting
Drummondville, Quebec, Canada, J2B 7T1
Pfizer Investigational Site Not yet recruiting
Montreal, Quebec, Canada, H1T 1C8
Pfizer Investigational Site Recruiting
Sherbrooke, Quebec, Canada, J1H 1Z1
Pfizer Investigational Site Recruiting
St-Romuald, Quebec, Canada, G6W 5M6
Colombia
Pfizer Investigational Site Recruiting
Medellin, Antioquia, Colombia
Pfizer Investigational Site Not yet recruiting
Medellin, Antioquia, Colombia
Pfizer Investigational Site Recruiting
Barranquilla, Atlantico, Colombia, 0
Pfizer Investigational Site Recruiting
Barranquilla, Atlantico, Colombia
Pfizer Investigational Site Not yet recruiting
Barranquilla, Atlantico, Colombia
Pfizer Investigational Site Recruiting
Cartagena, Bolivar, Colombia
Pfizer Investigational Site Recruiting
Manizales, Caldas, Colombia
Pfizer Investigational Site Recruiting
Bogota, Cundinamarca, Colombia
Pfizer Investigational Site Recruiting
Armenia, Quindio, Colombia
Pfizer Investigational Site Recruiting
Espinal, Tolima, Colombia
France
Pfizer Investigational Site Not yet recruiting
Nantes, France, 44200
Pfizer Investigational Site Recruiting
Tourcoing, France, 59200
Hungary
Pfizer Investigational Site Recruiting
Ajka, Hungary, 8400
Pfizer Investigational Site Recruiting
Baja, Hungary, 6500
Pfizer Investigational Site Recruiting
Baja, Hungary, H 6500
Pfizer Investigational Site Recruiting
Balatonfured, Hungary, 8230
Pfizer Investigational Site Not yet recruiting
Debrecen, Hungary, 4032
Pfizer Investigational Site Not yet recruiting
Gyongyos, Hungary, 3200
Pfizer Investigational Site Recruiting
Miskolc, Hungary, 3526
Pfizer Investigational Site Recruiting
Mosonmagyarovar, Hungary, 9200
Pfizer Investigational Site Not yet recruiting
Pecs, Hungary, 7624
Pfizer Investigational Site Recruiting
Zalaegerszeg, Hungary, 8900
Lithuania
Pfizer Investigational Site Recruiting
Kaunas, Lithuania, LT-50184
Pfizer Investigational Site Recruiting
Kaunas, Lithuania, LT-48259
Pfizer Investigational Site Recruiting
Klaipeda, Lithuania, LT-92288
Pfizer Investigational Site Not yet recruiting
Vilnius, Lithuania, LT-08661
Romania
Pfizer Investigational Site Recruiting
Craiova, Dolj, Romania, 200642
Pfizer Investigational Site Recruiting
Brasov, Romania, 500286
Pfizer Investigational Site Recruiting
Bucuresti, Romania, 010825
Pfizer Investigational Site Not yet recruiting
Cluj-Napoca, Romania, 400349
Spain
Pfizer Investigational Site Recruiting
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
Pfizer Investigational Site Recruiting
Santiago de Compostela, Galicia, Spain, 15706
Pfizer Investigational Site Recruiting
Pozuelo de Alarcon, Madrid, Spain, 28223
Pfizer Investigational Site Not yet recruiting
Barcelona, Spain, 08035
Pfizer Investigational Site Not yet recruiting
Madrid, Spain, 28040
Pfizer Investigational Site Recruiting
Madrid, Spain, 28046
Pfizer Investigational Site Recruiting
Zaragoza, Spain, 50009
Taiwan
Pfizer Investigational Site Not yet recruiting
New Taipei City, Taiwan, 23148
Pfizer Investigational Site Not yet recruiting
Taichung, Taiwan, 40705
Pfizer Investigational Site Recruiting
Taichung, Taiwan, 40447
Pfizer Investigational Site Recruiting
Taipei, Taiwan, 11217
United Kingdom
Pfizer Investigational Site Not yet recruiting
Antrim, Northern Ireland, United Kingdom, BT41 3AE
Pfizer Investigational Site Recruiting
Addlestone, Surrey, United Kingdom, KT15 2BH
Pfizer Investigational Site Recruiting
Dundee, United Kingdom, DD1 9SY
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
  More Information

Additional Information:
No publications provided

Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT01968967     History of Changes
Other Study ID Numbers: B1481020
Study First Received: October 21, 2013
Last Updated: July 24, 2014
Health Authority: United States: Food and Drug Administration

Keywords provided by Pfizer:
mixed dyslipidemia
high risk of cardiovascular events
multiple cardiovascular disease risk factors

Additional relevant MeSH terms:
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on August 28, 2014